Cargando…

Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosa

AIMS: To report the safety and efficacy of intravitreal aflibercept (Eylea) (ivA) for retinitis pigmentosa-associated cystoid macular oedema (RP-CMO) at 12 months via mean central macular thickness (CMT) and reported adverse events. METHODS: A prospective, exploratory, phase II, non-randomised, sing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strong, Stacey A, Peto, Tunde, Bunce, Catey, Xing, Wen, Georgiou, Michalis, Esposti, Simona Degli, Kalitzeos, Angelos, Webster, Andrew, Michaelides, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577098/ https://www.ncbi.nlm.nih.gov/pubmed/32041720 http://dx.doi.org/10.1136/bjophthalmol-2019-315152

Ejemplares similares

Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report
por: Strong, Stacey A., et al.
Publicado: (2016)

Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention
por: Strong, S, et al.
Publicado: (2017)

Correction: Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)
por: Sivaprasad, Sobha, et al.
Publicado: (2013)

Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)
por: Sivaprasad, Sobha, et al.
Publicado: (2013)

Retinal arteriolar oxygen saturation predicts the need for intravitreal aflibercept in patients with diabetic macular oedema
por: Blindbæk, Søren Leer, et al.
Publicado: (2020)

Novel disease-causing variant in RDH12 presenting with autosomal dominant retinitis pigmentosa
por: Muthiah, Manickam Nick, et al.
Publicado: (2022)

QUANTITATIVE ANALYSIS OF HYPERAUTOFLUORESCENT RINGS TO CHARACTERIZE THE NATURAL HISTORY AND PROGRESSION IN RPGR-ASSOCIATED RETINOPATHY
por: Tee, James J. L., et al.
Publicado: (2018)

Efficacy of additional topical betamethasone in persistent cystoid macular oedema after carbonic anhydrase inhibitor treatments in retinitis pigmentosa
por: Kitahata, Shohei, et al.
Publicado: (2018)

Transient Cystoid Macular Oedema in Multiple Choroidal Naevi
por: Ziahosseini, Kimia, et al.
Publicado: (2013)

Progressive cone and cone-rod dystrophies: clinical features, molecular genetics and prospects for therapy
por: Gill, Jasdeep S, et al.
Publicado: (2019)

Intravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa - a first case report and short review of the literature
por: Moustafa, Giannis-Aimant, et al.
Publicado: (2015)

A treat and extend protocol with Aflibercept for cystoid macular oedema secondary to central retinal vein occlusion – an 18-month prospective cohort study
por: O’Day, Roderick, et al.
Publicado: (2020)

Cystoid macular oedema in Cogans syndrome-a case report
por: Pherwani, Anupama, et al.
Publicado: (2008)

Acetazolamide for Cystoid Macular Oedema in Bietti Crystalline Retinal Dystrophy
por: Broadhead, Geoffrey K, et al.
Publicado: (2014)

Early Bilateral Cystoid Macular Oedema Secondary to Fingolimod in Multiple Sclerosis
por: Liu, Lei, et al.
Publicado: (2012)

Adaptive optics imaging of inherited retinal diseases
por: Georgiou, Michalis, et al.
Publicado: (2018)

Aflibercept versus ranibizumab for treating persistent diabetic macular oedema
por: ROA Vandekerckhove, Kristof
Publicado: (2015)

Cystoid macular oedema associated with Rosai–Dorfman disease: a case report
por: Siqueira, Rubens Camargo, et al.
Publicado: (2017)

Sector Retinitis Pigmentosa: Extending the Molecular Genetics Basis and Elucidating the Natural History
por: Georgiou, Michalis, et al.
Publicado: (2021)

Intravitreal aflibercept for treatment of macular oedema associated with immune recovery uveitis
por: Rothova, Aniki, et al.
Publicado: (2020)

Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
por: Shibeeb, O'Sam, et al.
Publicado: (2014)

Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
por: Majumder, Parthopratim Dutta, et al.
Publicado: (2016)

Ipilimumab/nivolumab: Bilateral acute anterior uveitis and cystoid macular oedema: case report
Publicado: (2022)

Tozinameran: Panuveitis, iridis rubeosis re-activation and cystoid macular oedema: case report
Publicado: (2022)

Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
por: Cornish, E. E., et al.
Publicado: (2023)

Intravitreal and Subtenon Depot Triamcinolone as Treatment of Retinitis Pigmentosa Associated Cystoid Macular Edema
por: Barge, Sidnei, et al.
Publicado: (2013)

Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis
por: Chen, Chen, et al.
Publicado: (2022)

Cross-Sectional and Longitudinal Assessment of the Ellipsoid Zone in Childhood-Onset Stargardt Disease
por: Tanna, Preena, et al.
Publicado: (2019)

Longitudinal Assessment of Retinal Structure in Achromatopsia Patients With Long-Term Follow-up
por: Hirji, Nashila, et al.
Publicado: (2018)

Photoreceptor Structure in GNAT2-Associated Achromatopsia
por: Georgiou, Michalis, et al.
Publicado: (2020)

Functional and structural efficacy of a novel combinational therapy of aflibercept and timely focal/grid photocoagulation in diabetic macular oedema: do clinical study results compare favourably with a standard‐of‐care treated real‐world population?
por: Jørgensen, Mathias M., et al.
Publicado: (2022)

Cross-Sectional and Longitudinal Assessment of Retinal Sensitivity in Patients With Childhood-Onset Stargardt Disease
por: Tanna, Preena, et al.
Publicado: (2018)

Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy
por: Newcott, Eric K., et al.
Publicado: (2015)

Topical non‐steroidal anti‐inflammatory drugs are not the mainstay of prophylaxis and treatment for pseudophakic cystoid macular oedema
por: Levitz, Lewis M., et al.
Publicado: (2019)

Tangential vitreous traction: a possible mechanism of development of cystoid macular edema in retinitis pigmentosa
por: Takezawa, Mikiko, et al.
Publicado: (2011)

Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema
por: Foos, William F, et al.
Publicado: (2022)

Aflibercept in clinical practice; visual acuity, injection numbers and adherence to treatment, for diabetic macular oedema in 21 UK hospitals over 3 years
por: Talks, S. J., et al.
Publicado: (2021)

Prospective Cohort Study of Childhood-Onset Stargardt Disease: Fundus Autofluorescence Imaging, Progression, Comparison with Adult-Onset Disease, and Disease Symmetry
por: Georgiou, Michalis, et al.
Publicado: (2020)

Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema
por: Zhu, Yanxia, et al.
Publicado: (2022)

Spectral-domain optical coherence tomography evaluation of postoperative cystoid macular oedema following phacoemulsification with intraoperative complication
por: Khaw, Keat Ween, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m558te10bcu9lc5c2mptjlr63m